FIGURE

Fig. 6

ID

ZDB-FIG-220628-129

Publication

Xu et al., 2022 - Reversion of MRAP2 Protein Sequence Generates a Functional Novel Pharmacological Modulator for MC4R Signaling

Other Figures

All Figure Page

Back to All Figure Page

Fig. 6

Wild−type and reversed Mrap2a/b differently affect the pharmacological profiles of zMc4r. (A–C) Dose−responsive stimulation of MC4R by α−MSH−induced cAMP production with different ratios of wild-type and reversed Mrap2a/b (A,B) or MRAP2 (C). (D–F) Dose−responsive inhibition of MC4R by antagonist SHU9119 with different ratios of wild-type and reversed Mrap2a/b (D,E) or MRAP2 (F). (G–I) The basal cAMP level caused by transfected MC4R, MRAP2 and RMRAP2 in the absence of an agonist. Data were analyzed by one−way ANOVA and shown as mean ± SEM of three replicates. ns (not significant difference), * p < 0.05, ** p < 0.01, *** p < 0.001 and **** p < 0.0001. 2a: Mrap2a, R2a: RMrap2a, 2b: Mrap2b, R2b: RMrap2b, M2: MRAP2, RM2: RMRAP2.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Biology (Basel)